The Role of miRNAs in Bone Metastasis and their Significance in the Detection of Bone Metastasis: A Review of the Published Data

References

• Brown JE , CookRJ, MajorPet al. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J. Natl. Cancer Inst.97(1), 59–69 (2005).
   PubMed Web of Science ®Google Scholar
• Weilbaecher KN , GuiseTA, McCauleyLK. Cancer to bone: a fatal attraction. Nat. Rev. Cancer11(6), 411–425 (2011).
   PubMed Web of Science ®Google Scholar
• Barton MK . Denosumab an option for patients with bone metastasis from breast cancer. CA Cancer J. Clin.61(3), 135–136 (2011).
   PubMedGoogle Scholar
• Sturge J , CaleyMP, WaxmanJ. Bone metastasis in prostate cancer: emerging therapeutic strategies. Nat. Rev. Clin. Oncol.8(6), 357–368 (2011).
   PubMed Web of Science ®Google Scholar
• Suva LJ , WashamC, NicholasRW, GriffinRJ. Bone metastasis: mechanisms and therapeutic opportunities. Nat. Rev. Endocrinol.7(4), 208–218 (2011).
   PubMed Web of Science ®Google Scholar
• Huang Q , OuyangX. Biochemical-markers for the diagnosis of bone metastasis: a clinical review. Cancer Epidemiol.36(1), 94–98 (2012).
   PubMed Web of Science ®Google Scholar
• Kamiya N , SuzukiH, EndoTet al. Clinical usefulness of bone markers in prostate cancer with bone metastasis. Int. J. Urol.19(11), 968–979 (2012).
   PubMed Web of Science ®Google Scholar
• Volinia S , CalinGA, LiuCGet al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA103(7), 2257–2261 (2006).
   PubMed Web of Science ®Google Scholar
• Harquail J , BenzinaS, RobichaudGA. MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis. Cancer Biomark.11(6), 269–280 (2012).
   PubMed Web of Science ®Google Scholar
• Suda T , TakahashiN, UdagawaN, JimiE, GillespieMT, MartinTJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev.20(3), 345–357 (1999).
   PubMed Web of Science ®Google Scholar
• Sims NA , GooiJH. Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption. Semin. Cell Dev. Biol.19(5), 444–451 (2008).
   PubMed Web of Science ®Google Scholar
• Hanahan D , WeinbergRA. Hallmarks of cancer: the next generation. Cell144(5), 646–674 (2011).
   PubMed Web of Science ®Google Scholar
• Patel LR , CamachoDF, ShiozawaY, PientaKJ, TaichmanRS. Mechanisms of cancer cell metastasis to the bone: a multistep process. Future Oncol.7(11), 1285–1297 (2011).
   PubMed Web of Science ®Google Scholar
• Wickramasinghe NS , ManavalanTT, DoughertySM, RiggsKA, LiY, KlingeCM. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res.37(8), 2584–2595 (2009).
   PubMed Web of Science ®Google Scholar
• Hashimi ST , FulcherJA, ChangMH, GovL, WangS, LeeB. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinateregulation of dendritic cell differentiation. Blood114(2), 404–414 (2009).
   PubMed Web of Science ®Google Scholar
• Han M , LiuM, WangYet al. Antagonism of miR-21 reverses epithelial–mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN. PLoS ONE7(6), e39520 (2012).
   PubMed Web of Science ®Google Scholar
• Han M , LiuM, WangYet al. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial–mesenchymal transitionconsistent with cancer stem cell characteristics in MCF-7 cells. Mol. Cell. Biochem.363(1–2), 427–436 (2012).
   PubMed Web of Science ®Google Scholar
• Ma L , YoungJ, PrabhalaHet al. MiR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol.12(3), 247–256 (2010).
   PubMed Web of Science ®Google Scholar
• Zhuang G , WuX, JiangZet al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J.31(17), 3513–3523 (2012).
   PubMed Web of Science ®Google Scholar
• Gebeshuber CA , ZatloukalK, MartinezJ. MiR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep.10(4), 400–405 (2009).
   PubMed Web of Science ®Google Scholar
• Wang H , ZhuY, ZhaoMet al. MiRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin β1 and matrix metalloproteinase 2 (MMP2). PLoS ONE8(8), e70192 (2013).
   PubMed Web of Science ®Google Scholar
• Kuo PL , LiaoSH, HungJY, HuangMS, HsuYL. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormonerelated protein. Biochim. Biophys. Acta1830(6), 3756–3766 (2013).
   PubMed Web of Science ®Google Scholar
• Png KJ , HalbergN, YoshidaM, TavazoieSF. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature481(7380), 190–194 (2011).
   PubMed Web of Science ®Google Scholar
• Deng Y , DengH, BiFet al. MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines. Int. J. Biol. Sci.7(1), 133–137 (2011).
   PubMed Web of Science ®Google Scholar
• Hu J , GuoH, LiHet al. MiR-145 regulates epithelial to mesenchymal transition of breast cancer cells by targeting Oct4. PLoS ONE7(9), e45965 (2012).
   PubMed Web of Science ®Google Scholar
• Peng X , GuoW, LiuTet al. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS ONE6(5), e20341 (2011).
   PubMed Web of Science ®Google Scholar
• Guo W , RenD, ChenXet al. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145. J. Cell Biochem.114(7), 1606–1615 (2013).
   PubMed Web of Science ®Google Scholar
• Ren D , WangM, GuoWet al. Wild-type p53 suppresses the epithelial–mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR-145. Int. J. Oncol.42(4), 1473–1481 (2013).
   PubMed Web of Science ®Google Scholar
• Shin KH , BaeSD, HongHS, KimRH, KangMK, ParkNH. MiR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochem. Biophys. Res. Commun.404(4), 896–902 (2011).
   PubMed Web of Science ®Google Scholar
• Liu M , WangJ, HuangH, HouJ, ZhangB, WangA. MiR-181a–Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma. Biochem. Biophys. Res. Commun.441(2), 364–370 (2013).
   PubMed Web of Science ®Google Scholar
• Gibbons DL , LinW, CreightonCJet al. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev.23(18), 2140–2151 (2009).
   PubMed Web of Science ®Google Scholar
• Brabletz S , BajdakK, MeidhofSet al. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J.30(4), 770–782 (2011).
   PubMed Web of Science ®Google Scholar
• Vallejo DM , CaparrosE, DominguezM. Targeting Notch signalling by the conserved miR-8/200 microRNA family in development and cancer cells. EMBO J.30(4), 756–769 (2011).
   PubMed Web of Science ®Google Scholar
• Liu J , RuanB, YouNet al. Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the β-catenin pathway in hepatic oval cells. PLoS ONE8(11), e79409 (2013).
   PubMed Web of Science ®Google Scholar
• Pollari S , LeivonenSK, PeräläM, FeyV, KäkönenSM, KallioniemiO. Identification of microRNAs inhibiting TGF-β -induced IL-11 production in bone metastatic breast cancer cells. PLoS ONE7(5), e37361 (2012).
   PubMed Web of Science ®Google Scholar
• Lim PK , BlissSA, PatelSAet al. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res.71(5), 1550–1560 (2011).
   PubMed Web of Science ®Google Scholar
• Ell B , MercataliL, IbrahimTet al. Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis. Cancer Cell24(4), 542–556 (2013).
   PubMed Web of Science ®Google Scholar
• Gong M , MaJ, GuillemetteRet al. MiR-335 inhibits small cell lung cancer bone metastases via IGF-IR and RANKL pathways. Mol. Cancer Res.12(1), 101–110 (2014).
   PubMed Web of Science ®Google Scholar
• Tavazoie SF , AlarcónC, OskarssonTet al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature451(7175), 147–152 (2008).
   PubMed Web of Science ®Google Scholar
• Oskarsson T , AcharyyaS, ZhangXHet al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med.17(7), 867–874 (2011).
   PubMed Web of Science ®Google Scholar
• Vetter G , SaumetA, MoesMet al. MiR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Oncogene29(31), 4436–4448 (2010).
   PubMed Web of Science ®Google Scholar
• Paterson EL , KazenwadelJ, BertAG, Khew-GoodallY, RuszkiewiczA, GoodallGJ. Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression. Neoplasia15(2), 180–191 (2013).
   PubMed Web of Science ®Google Scholar
• Cong N , DuP, ZhangAet al. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol. Rep.29(4), 1579–1587 (2013).
   PubMed Web of Science ®Google Scholar
• Gregory PA , BertAG, PatersonELet al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol.10(5), 593–601 (2008).
   PubMed Web of Science ®Google Scholar
• Aydoğdu E , KatchyA, TsoukoEet al. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer. Carcinogenesis33(8), 1502–1511 (2012).
   PubMed Web of Science ®Google Scholar
• Pacurari M , AddisonJB, BondalapatiNet al. The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. Int. J. Oncol.43(2), 548–560 (2013).
   PubMed Web of Science ®Google Scholar
• Zidar N , BoštjančičE, GaleNet al. Downregulation of micro-RNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck – hallmark of epithelial–mesenchymal transition. Hum. Pathol.42(4), 482–488 (2011).
   PubMed Web of Science ®Google Scholar
• Bendoraite A , KnoufEC, GargKSet al. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol. Oncol.116(1), 117–124 (2010).
   PubMed Web of Science ®Google Scholar
• Maitah MY , AliS, AhmadA, GadgeelS, SarkarFH. Up-regulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS ONE6(1), e16068 (2011).
   PubMed Web of Science ®Google Scholar
• Wu H , XiaoZ, WangK, LiuW, HaoQ. MiR-145 is down-regulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1. Biochem. Biophys. Res. Commun.441(4), 693–700 (2013).
   PubMed Web of Science ®Google Scholar
• Yin Y , YanZP, LuNNet al. Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1. Biochim. Biophys. Acta1829(2), 239–247 (2013).
   PubMed Web of Science ®Google Scholar
• Xu Q , LiuLZ, QianXet al. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res.40(2), 761–774 (2012).
   PubMed Web of Science ®Google Scholar
• Chen X , GongJ, ZengHet al. MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res.70(7), 2728–2738 (2010).
   PubMed Web of Science ®Google Scholar
• Zhai XF , FangFF, LiuQ, MengYB, GuoYY, ChenZ. MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells. BMC Complement. Altern. Med.13, 325 (2013).
   PubMed Web of Science ®Google Scholar
• Bisso A , FaleschiniM, ZampaFet al. Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer. Cell Cycle12(11), 1679–1687 (2013).
   PubMed Web of Science ®Google Scholar
• Fei J , LiY, ZhuX, LuoX. MiR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML). PLoS ONE7(3), e32834 (2012).
   PubMed Web of Science ®Google Scholar
• Chen DL , WangDS, WuWJet al. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis34(4), 803–811 (2013).
   PubMed Web of Science ®Google Scholar
• Luo C , TettehPW, MerzPRet al. MiR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes. J. Invest. Dermatol.133(3), 768–775 (2013).
   PubMed Web of Science ®Google Scholar
• Balaguer F , LinkA, LozanoJJet al. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res.70(16), 6609–6618 (2010).
   PubMed Web of Science ®Google Scholar
• Langevin SM , StoneRA, BunkerCH, GrandisJR, SobolRW, TaioliE. MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis31(5), 864–870 (2010).
   PubMed Web of Science ®Google Scholar
• Sengupta S , den BoonJA, ChenIHet al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellularmatrix proteins. Proc. Natl Acad. Sci. USA105(15), 5874–5878 (2008).
   PubMed Web of Science ®Google Scholar
• Fabbri M , GarzonR, CimminoAet al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA104(40), 15805–15810 (2007).
   PubMed Web of Science ®Google Scholar
• Thomas M , Lange-GrünwellerK, WeirauchUet al. The proto -oncogene Pim-1 is a target of miR-33a. Oncogene31(7), 918–928 (2012).
   PubMed Web of Science ®Google Scholar
• Hemingway F , TaylorR, KnowlesHJ, AthanasouNA. RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II. Bone48(4), 938–944 (2011).
   PubMed Web of Science ®Google Scholar
• Guo C , SahJF, BeardL, WillsonJK, MarkowitzSD, GudaK. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer47(11), 939–946 (2008).
   PubMed Web of Science ®Google Scholar
• Feng R , ChenX, YuYet al. MiR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett.298(1), 50–63 (2010).
   PubMed Web of Science ®Google Scholar
• Jusufović E , RijavecM, KeserDet al. Let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non-small-cell lung cancer. PLoS ONE7(9), e45577 (2012).
   PubMed Web of Science ®Google Scholar
• Bao L , YanY, XuCet al. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Cancer Lett.337(2), 226–236 (2013).
   PubMed Web of Science ®Google Scholar
• Zhao FL , HuGD, WangXF, ZhangXH, ZhangYK, YuZS. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer. J. Int. Med. Res.40(3), 859–866 (2012).
   PubMed Web of Science ®Google Scholar
• Xie L , YangZ, LiGet al. Genome-wide identification of bone metastasis-related microRNAs in lung adenocarcinoma by high-throughput sequencing. PLoS ONE8(4), e61212 (2013).
   PubMed Web of Science ®Google Scholar
• Valencia K , Martín-FernándezM, ZanduetaCet al. MiR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis. Bone52(1), 532–539 (2013).
   PubMed Web of Science ®Google Scholar
• Hess KR , VaradhacharyGR, TaylorSHet al. Metastatic patterns in adenocarcinoma. Cancer106(7), 1624–1633 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang HL , QinXJ, CaoDLet al. An elevated serum miR-141 level in patients with bone-metastatic prostate cancer is correlated with more bone lesions. Asian J. Androl.15(2), 231–235 (2013).
   PubMed Web of Science ®Google Scholar